Recombinant vaccinia virus (investigational)

null · SillaJen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant vaccinia virus (investigational), covering 2022-10-27 to 2022-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma [Phase 1, Phase 2]